TABLE 3.

Receiver operating characteristic curve analysis of hepatic encephalopathy.

Metabolites	AUC	95% CI	p-value
Abiraterone sulfate	0.734	0.478–0.991	0.0716
erythro-6,8-Heneicosanediol	0.703	0.418–0.988	0.1138
2-Amino-4-oxo-6-(1′,2′,3′-trihydroxypropyl)-diquinoid-7,8-dihydroxypterin	0.734	0.478–0.991	0.0716
MG (0:0/a-25:0/0:0)[rac]	0.719	0.281–1.000	0.1007
TG (16:0/16:0/20:1 (11Z))	0.742	0.327–1.000	0.0781
GDP-4-Dehydro-6-deoxy-D-mannose	0.703	0.402–1.000	0.1035
(1R,2R)-3-oxo-2-pentyl-cyclopentanehexanoic acid	0.703	0.451–0.955	0.1179
2-Hydroxy-4-trifluoromethyl benzoic acid	0.766	0.486–1.000	0.0594
Codeine-6-glucuronide	0.766	0.531–1.000	0.0511
PG (20:0/0:0)	0.750	0.495–1.000	0.0689
PS(20:0/18:1 (11Z))	0.750	0.493–1.000	0.0623
MG (a-25:0/0:0/0:0)[rac]	0.836	0.632–1.000	0.0236

Abbreviations: AUC, area under the curve; 95% CI, 95% confidence interval.